Penn Pharmaceutical Services, a leading UK provider of integrated pharmaceutical outsourcing services, has increased its total number of Qualified Persons (QP) to seven, with QP status being awarded to head of compliance, Matthew Jaynes.
Jaynes joined Penn in 1993 as a member of the analytical development team before moving to the quality control (QC) division, first as an analyst, then as a supervisor. He was made head of QC in 2002, head of both QA and QC the following year and became head of compliance in 2005.
In his new role as a QP, Jaynes will now also have the authority to conduct QP audits and QP release products, investigational medicinal products and commercial drug products.
'Since the implementation of the Clinical Trials Directive in May 2004, there has been a general increase in demand in our business sector for QP services,' said Craig Rennie, chairman and ceo at Penn.
Penn's QPs all have extensive experience of working with worldwide clients, particularly those from Japan and North America, to ensure that importation procedures and EU compliance issues for new drug candidates can and have been addressed.